NewGenIvf Group Limited
NIVF
$0.63
$0.034.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 596.90K | 36.10K | -524.70K | -80.90K | 41.50K |
| Total Depreciation and Amortization | 177.00K | 191.60K | 206.20K | 193.30K | 142.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -188.50K | -182.70K | -176.90K | 27.30K | -40.30K |
| Change in Net Operating Assets | -13.95M | -10.86M | -7.77M | -2.96M | 4.00M |
| Cash from Operations | -13.37M | -10.82M | -8.26M | -2.82M | 4.15M |
| Capital Expenditure | -106.20K | -79.60K | -53.00K | -67.80K | -80.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.48M | -3.74M | 100.00 | -16.30K | -1.00K |
| Cash from Investing | -7.58M | -3.82M | -53.00K | -84.20K | -81.30K |
| Total Debt Issued | 15.18M | 12.14M | 9.09M | 3.43M | 5.80M |
| Total Debt Repaid | 0.00 | -3.20K | -6.40K | -130.00K | -6.40K |
| Issuance of Common Stock | 127.60K | 127.60K | 127.60K | 0.00 | 192.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 7.68M | 3.57M | -537.60K | -164.60K | -10.18M |
| Cash from Financing | 22.99M | 15.83M | 8.68M | 3.14M | -4.19M |
| Foreign Exchange rate Adjustments | -614.50K | -284.80K | 44.90K | -94.10K | 226.90K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | 1.42M | 914.10K | 403.70K | 132.60K | 106.80K |